288 related articles for article (PubMed ID: 30456745)
1. Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.
Every-Palmer S; Inns SJ; Grant E; Ellis PM
CNS Drugs; 2019 Jan; 33(1):81-91. PubMed ID: 30456745
[TBL] [Abstract][Full Text] [Related]
2. The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.
Every-Palmer S; Ellis PM; Nowitz M; Stanley J; Grant E; Huthwaite M; Dunn H
CNS Drugs; 2017 Jan; 31(1):75-85. PubMed ID: 27826741
[TBL] [Abstract][Full Text] [Related]
3. Clozapine-treated Patients Have Marked Gastrointestinal Hypomotility, the Probable Basis of Life-threatening Gastrointestinal Complications: A Cross Sectional Study.
Every-Palmer S; Nowitz M; Stanley J; Grant E; Huthwaite M; Dunn H; Ellis PM
EBioMedicine; 2016 Mar; 5():125-34. PubMed ID: 27077119
[TBL] [Abstract][Full Text] [Related]
4. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases.
Palmer SE; McLean RM; Ellis PM; Harrison-Woolrych M
J Clin Psychiatry; 2008 May; 69(5):759-68. PubMed ID: 18452342
[TBL] [Abstract][Full Text] [Related]
5. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
Every-Palmer S; Ellis PM
CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
[TBL] [Abstract][Full Text] [Related]
6. Generalized transit delay on wireless motility capsule testing in patients with clinical suspicion of gastroparesis, small intestinal dysmotility, or slow transit constipation.
Kuo B; Maneerattanaporn M; Lee AA; Baker JR; Wiener SM; Chey WD; Wilding GE; Hasler WL
Dig Dis Sci; 2011 Oct; 56(10):2928-38. PubMed ID: 21625964
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal hypomotility: an under-recognised life-threatening adverse effect of clozapine.
Flanagan RJ; Ball RY
Forensic Sci Int; 2011 Mar; 206(1-3):e31-6. PubMed ID: 20719440
[TBL] [Abstract][Full Text] [Related]
8. The Wireless Motility Capsule: a One-Stop Shop for the Evaluation of GI Motility Disorders.
Saad RJ
Curr Gastroenterol Rep; 2016 Mar; 18(3):14. PubMed ID: 26908282
[TBL] [Abstract][Full Text] [Related]
9. Focussing on the fundaments - assessing and treating Clozapine Induced Gastrointestinal Hypomotility.
Blackman G; Kapila A; Grosskopf CM; Dratcu L
Int J Psychiatry Clin Pract; 2020 Mar; 24(1):18-19. PubMed ID: 31910056
[No Abstract] [Full Text] [Related]
10. Clozapine induced gastrointestinal hypomotility: A potentially life threatening adverse event. A review of the literature.
West S; Rowbotham D; Xiong G; Kenedi C
Gen Hosp Psychiatry; 2017 May; 46():32-37. PubMed ID: 28622812
[TBL] [Abstract][Full Text] [Related]
11. Clozapine and Gastrointestinal Hypomotility.
Cohen D
CNS Drugs; 2017 Dec; 31(12):1083-1091. PubMed ID: 29230675
[TBL] [Abstract][Full Text] [Related]
12. Blunting of Colon Contractions in Diabetics with Gastroparesis Quantified by Wireless Motility Capsule Methods.
Coleski R; Wilding GE; Semler JR; Hasler WL
PLoS One; 2015; 10(10):e0141183. PubMed ID: 26510137
[TBL] [Abstract][Full Text] [Related]
13. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology.
Sarosiek I; Selover KH; Katz LA; Semler JR; Wilding GE; Lackner JM; Sitrin MD; Kuo B; Chey WD; Hasler WL; Koch KL; Parkman HP; Sarosiek J; McCallum RW
Aliment Pharmacol Ther; 2010 Jan; 31(2):313-22. PubMed ID: 19814743
[TBL] [Abstract][Full Text] [Related]
14. Upper gut dysmotility in slow-transit constipation: is it evidence for a pan-enteric neurological deficit in severe slow transit constipation?
Spiller RC
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):693-6. PubMed ID: 10445784
[TBL] [Abstract][Full Text] [Related]
15. Colonic transit diagnostic test shows significant gastrointestinal hypomotility in clozapine-treated patients in comparison with subjects treated with other antipsychotics.
Baptista T; Carrizo E; Fernandez E; Connell L; Servigna M; Parra A; Quintero J; Pabón A; Sandia I; Uzcáteguid E; Serrano A; Pirela N; Villarreal L
Schizophr Res; 2015 Aug; 166(1-3):207-11. PubMed ID: 26032569
[TBL] [Abstract][Full Text] [Related]
16. Reporting of clozapine-induced gastrointestinal hypomotility and factors associated with fatal outcomes in Canada: A pharmacovigilance database study.
Liu CL; Maruf AA; Bousman CA
Psychiatry Res; 2020 Aug; 290():113048. PubMed ID: 32474068
[TBL] [Abstract][Full Text] [Related]
17. Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit.
Parkman HP; Sharkey E; McCallum RW; Hasler WL; Koch KL; Sarosiek I; Abell TL; Kuo B; Shulman RJ; Grover M; Farrugia G; Schey R; Tonascia J; Hamilton F; Pasricha PJ;
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):546-558.e5. PubMed ID: 33130007
[TBL] [Abstract][Full Text] [Related]
18. Clozapine-induced gastrointestinal hypomotility.
Vella-Brincat J; McKean A; Barclay M
Australas Psychiatry; 2011 Oct; 19(5):450-1. PubMed ID: 21995363
[No Abstract] [Full Text] [Related]
19. Constipation screening in people taking clozapine: A diagnostic accuracy study.
Every-Palmer S; Inns SJ; Ellis PM
Schizophr Res; 2020 Jun; 220():179-186. PubMed ID: 32245597
[TBL] [Abstract][Full Text] [Related]
20. Effect of endotoxin on canine gastrointestinal motility and transit.
Cullen JJ; Caropreso DK; Ephgrave KS
J Surg Res; 1995 Jan; 58(1):90-5. PubMed ID: 7830412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
